Churchill Financial Advisors’s ResMed RMD Stock Holding History

Churchill Financial Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,215	Closed	-$273K	–	130
2026 Q1	$273K	Sell	1,215 -239	-16%	-$59.6K	0.06%	114
2025 Q4	$350K	Buy	+1,454	New	+$372K	0.11%	102

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Churchill Financial Advisors's RMD Position: Q2 2026 in Review

Churchill Financial Advisors sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,215 shares — an estimated $273K sold.

Churchill Financial Advisors first reported a position in RMD in Q4 2025 and held it in 2 quarters. The position peaked at $350K in Q4 2025. 884 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Churchill Financial Advisors reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
Churchill Financial Advisors sold 1,215 ResMed shares in Q2 2026, an estimated $273K.
Churchill Financial Advisors first reported a position in ResMed in Q4 2025 and held it in 2 quarters.
Churchill Financial Advisors's ResMed position peaked at $350K in Q4 2025.
884 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Churchill Financial Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.